Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Eur Rev Med Pharmacol Sci ; 21(13): 3134-3138, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28742191

RESUMO

OBJECTIVE: To evaluate the hormonal profile in three breast cancer patients who underwent controlled ovarian stimulation in the presence of the aromatase inhibitor letrozole. PATIENTS AND METHODS: In IVF University referral center, a case series of three breast cancer patients who underwent controlled ovarian stimulation (COS) with recombinant FSH and letrozole were investigated. Ovulation was induced with hCG (case No. 1) or with GnRH agonist (case No. 2-3). The primary outcome of our study was the detection of progesterone levels in the luteal phase. RESULTS: Very high progesterone values (mean 186.6 ± 43.6 ng/mL) during the luteal phase were recorded in all three cases. CONCLUSIONS: High progesterone levels can be related to the use of letrozole independently of the most commonly used trigger regimen. Although progesterone has long been considered a protective factor against breast cancer, several studies have demonstrated that progesterone could expand a transformation-sensitive stem cell population in the mammary glands. The estrogen negative feedback effect on the hypothalamus-pituitary axis and the disruption of steroid biosynthesis and could represent an intriguing reason behind this phenomenon. Our results highlight the need to evaluate further the increase in progesterone levels in the luteal phase in women with breast cancer undergoing COS with letrozole.


Assuntos
Inibidores da Aromatase/uso terapêutico , Neoplasias da Mama/tratamento farmacológico , Nitrilas/uso terapêutico , Progesterona/sangue , Triazóis/uso terapêutico , Adulto , Neoplasias da Mama/patologia , Gonadotropina Coriônica/administração & dosagem , Feminino , Hormônio Foliculoestimulante/administração & dosagem , Hormônio Foliculoestimulante/genética , Hormônio Foliculoestimulante/metabolismo , Hormônio Liberador de Gonadotropina/agonistas , Humanos , Letrozol , Fase Luteal , Indução da Ovulação , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/isolamento & purificação
3.
J Am Geriatr Soc ; 39(8): 778-84, 1991 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1906492

RESUMO

OBJECTIVE: To determine the reliability of rapid screening by clinically derived geriatric criteria in predicting outcomes of elderly hospitalized patients. DESIGN: Prospective cohort study of 985 patients screened at the time of hospital admission and followed for 1 year with respect to the outcomes of mortality, hospital readmission, and nursing home utilization. SETTING: Palo Alto Veterans Affairs Medical Center, a tertiary care teaching hospital. SUBJECTS: Male patients 65 years of age and older admitted to the Medical and Surgical services during the period from October 1, 1985 through September 30, 1986. RESULTS: Patients were grouped by specific screening criteria into three groups of increasing frailty: Independent, Frail, and Severely Impaired. Each criterion focused on a geriatric condition and was designed to serve as a marker for frailty. Increasing frailty was significantly correlated with increasing length of hospital stay (P less than 0.0001), nursing home utilization (P less than 0.0001), and mortality (P less than 0.0001). Multivariate analyses revealed that the clinical groups were more predictive of mortality and nursing home utilization than were age or Diagnosis-Related Groups (DRGs). Rehospitalization was unrelated to age, clinical group, or DRG, suggesting that utilization may not be driven by the clinical factors measured in this study. CONCLUSIONS: Rapid clinical screening using specific geriatric criteria is effective in identifying frail older subjects at risk for mortality and nursing home utilization. Our findings suggest that geriatric syndromes are more predictive of adverse outcomes than diagnosis per se. This well operationalized screening process is inexpensive as well as effective and could easily be introduced into other hospital settings.


Assuntos
Idoso Fragilizado , Avaliação Geriátrica , Hospitalização , Programas de Rastreamento/normas , Avaliação de Processos e Resultados em Cuidados de Saúde/normas , Atividades Cotidianas , Idoso , Estudos de Coortes , Grupos Diagnósticos Relacionados , Assistência Domiciliar/estatística & dados numéricos , Humanos , Tempo de Internação/estatística & dados numéricos , Masculino , Programas de Rastreamento/métodos , Mortalidade , Avaliação de Processos e Resultados em Cuidados de Saúde/métodos , Valor Preditivo dos Testes , Taxa de Sobrevida
5.
Blood Cells ; 9(3): 455-66, 1983.
Artigo em Inglês | MEDLINE | ID: mdl-6326898

RESUMO

Using an automated cytochemical analyzer used for routine differential counts, we have been able to demonstrate acquired myeloperoxidase deficiency in 102 patients at our institution. Clinical and laboratory data on these patients showed a high incidence of diabetes mellitus (25.5%) and thrombotic diseases (24.5%), as well as a strikingly constant hyperfibrinogenemia (mean = 635 mg/100 ml; range = 360-1015 mg/100 ml). In 4 additional acute leukemia patients in complete remission, a close time correlation was noted between acquired MPO deficiency, diffuse intravascular coagulation and relapse. These findings indicate the importance of the relationships between neutrophil granulocytes and blood coagulation, and suggest that similar changes in neutrophil MPO activity may represent an early morphological indicator of subclinical activation of blood coagulation.


Assuntos
Coagulação Sanguínea , Neutrófilos/enzimologia , Peroxidase/deficiência , Peroxidases/deficiência , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Diabetes Mellitus/enzimologia , Coagulação Intravascular Disseminada/enzimologia , Feminino , Fibrinogênio/metabolismo , Humanos , Lactente , Recém-Nascido , Leucemia Mieloide Aguda/enzimologia , Masculino , Pessoa de Meia-Idade , Peroxidase/sangue , Trombose/enzimologia
6.
An. Fac. Med. Montev ; 4(1): 41-58, 1981.
Artigo em Espanhol | LILACS | ID: lil-6218

RESUMO

Se realiza un estudio clinico epidemiologico en ninos y adultos para detectar el AgHBs y determinar su real importancia en la poblacion del Uruguay. Se observo un 6,4% de portadores de AgHBs en donantes de sangre, con un 15,5% de AcHBs; 16% de AgHBs en politransfundidos; 4% de AgHBs en ninos "sanos" y 12,6% en ninos internados con afecciones miscelaneas.En los casos clinicos se encontro el AgHBs en el 48,8% de las hepatitis agudas; en el 82,3% de las hepatitis prolongadas; en el 50% de las hepatitis cronicas persistentes y en el 77,7% de las hepatitis cronicas agresivas. En estos tres ultimos grupos el numero de pacientes estudiados es insuficiente para dar real valor a estas cifras. Se determino la importancia de la antigenuria asi como del estudio de la biopsia hepatica por inmunofluorescencia


Assuntos
Antígenos da Hepatite B , Doadores de Sangue , Imunofluorescência , Testes de Fixação do Látex
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA